Fling S P, Gold D P, Gregerson D S
Department of Microbiology, University of Minnesota, Minneapolis 55455.
Cell Immunol. 1992 Jul;142(2):275-86. doi: 10.1016/0008-8749(92)90289-2.
The restricted usage of particular T cell receptor beta chain genes in autoimmune disease was studied in LEW rats using T cell hybridomas specific for an immunodominant sequence of bovine retinal S-Ag, which induces experimental autoimmune uveoretinitis. T cell hybridomas from a pathogenic T cell line, R858, specific for residues 273-289 of bovine retinal S-Ag were analyzed in order to determine the contribution of their TCR V beta to self specificity as determined by recognition of the pathogenic epitope represented in the autologous rat S-Ag sequence. Six different, functional TCR rearrangements were expressed by the panel of hybridomas, including two distinct V beta 8.2 rearrangements and functional V beta 10, V beta 14, V beta 19 rearrangements, and an unidentified V beta gene. All hybridomas were Ag specific and reacted both to nonself-peptide derivatives as well as to self-peptide homologues. No unique pattern of peptide reactivity distinguished V beta 8.2+ hybridomas from V beta 8.2- hybridomas; all of the hybridomas were most reactive to the nonself sequences and reacted to self peptide with one to three orders of magnitude less sensitivity. However, all V beta 8.2+ hybridomas were much better responders overall and were activated by lower concentrations of all peptides than were V beta 8.2- hybridomas. Although V beta 8.2 gene usage is strongly associated with autoimmune pathology, these data show that in LEW rats several different TCR V beta genes are utilized in response to a short pathogenic sequence of this autoantigen and show that V beta 8.2 receptors are not uniquely self-reactive. However, the enhanced reactivity to Ag of V beta 8.2+ hybridomas relative to V beta 8.2- hybridomas specific for the same peptide may help explain the close association of V beta 8.2 TCR gene usage with pathogenicity found in autoimmune disease models.
利用对牛视网膜S抗原免疫显性序列具有特异性的T细胞杂交瘤,在LEW大鼠中研究了特定T细胞受体β链基因在自身免疫性疾病中的限制性使用情况,该序列可诱发实验性自身免疫性葡萄膜视网膜炎。对来自致病性T细胞系R858的T细胞杂交瘤进行分析,该细胞系对牛视网膜S抗原的273 - 289位残基具有特异性,目的是确定其TCR Vβ对自身特异性的贡献,这种自身特异性是通过识别自体大鼠S抗原序列中所代表的致病表位来确定的。一组杂交瘤表达了六种不同的功能性TCR重排,包括两种不同的Vβ8.2重排以及功能性Vβ10、Vβ14、Vβ19重排,还有一个未鉴定的Vβ基因。所有杂交瘤均具有抗原特异性,对非自身肽衍生物以及自身肽同源物均有反应。没有独特的肽反应模式能将Vβ8.2 +杂交瘤与Vβ8. –杂交瘤区分开来;所有杂交瘤对非自身序列反应最强,对自身肽的反应敏感性低一到三个数量级。然而,总体而言,所有Vβ8.2 +杂交瘤反应性更好,与Vβ8.2 –杂交瘤相比,被更低浓度的所有肽激活。尽管Vβ8.2基因的使用与自身免疫病理密切相关,但这些数据表明,在LEW大鼠中,几种不同的TCR Vβ基因被用于应对该自身抗原的短致病序列,并且表明Vβ8.2受体并非唯一具有自身反应性。然而,相对于对相同肽具有特异性的Vβ8.2 –杂交瘤,Vβ8.2 +杂交瘤对抗原的反应性增强,这可能有助于解释在自身免疫性疾病模型中发现的Vβ8.2 TCR基因使用与致病性之间的紧密关联。